AQUA HA
An innovative hybrid skin booster based on four molecular fractions of ultra-pure hyaluronic acid. Designed to deeply moisturize, increase elasticity and remodel tissues. The product provides a scientifically proven regenerative effect, restoring the skin's natural radiance without creating artificial volume and radically changing the appearance.
The product is based on a unique hybrid formula that combines microcrosslinked, high, medium and hydrolyzed hyaluronic acid fractions into a single molecular network stabilized by hydrogen bonds and thermal purification. This ensures perfect integration into tissues without the risk of nodules or irregularities.
The product is based on a unique hybrid formula that combines microcrosslinked, high, medium and hydrolyzed hyaluronic acid fractions into a single molecular network stabilized by hydrogen bonds and thermal purification. This ensures perfect integration into tissues without the risk of nodules or irregularities.
Fill in the fields and we will contact you!
Please check the correctness of your phone number before submitting the application!
Download the files and learn more about the product
Indications for use
The drug is adapted to the age needs of patients:
Age 25–35 years: intensive hydration, prevention of aging, elimination of the first dullness of the skin.
Age 35–50 years: correction of fine superficial wrinkles, recovery after sun exposure, work with loss of elasticity.
Age 50+: therapy of progressive thinning and deep dehydration of the skin, correction of pronounced textural changes.
Composition:
The total content of the active substance is 90 mg per 3 ml syringe.
Microcrosslinked hyaluronic acid (30 mg): formation of a stable hydroreservoir for up to 6 months.
High-molecular HA (21 mg / 1000–1500 kDa): restoration of barrier function and tissue elasticity.
Medium-molecular HA (121 mg / 300–500 kDa): activation of fibroblasts, triggering the synthesis of elastin and collagen types I, III.
Hydrolyzed sodium hyaluronate (18 mg / <50 kDa): enhancement of intercellular signaling, relief of inflammation.
Release form:
Box contents: 2 sterile syringes with a volume of 3 ml each.
Active ingredient concentration: 90 mg of HA in one syringe (30 mg/ml).
The drug is adapted to the age needs of patients:
Age 25–35 years: intensive hydration, prevention of aging, elimination of the first dullness of the skin.
Age 35–50 years: correction of fine superficial wrinkles, recovery after sun exposure, work with loss of elasticity.
Age 50+: therapy of progressive thinning and deep dehydration of the skin, correction of pronounced textural changes.
Composition:
The total content of the active substance is 90 mg per 3 ml syringe.
Microcrosslinked hyaluronic acid (30 mg): formation of a stable hydroreservoir for up to 6 months.
High-molecular HA (21 mg / 1000–1500 kDa): restoration of barrier function and tissue elasticity.
Medium-molecular HA (121 mg / 300–500 kDa): activation of fibroblasts, triggering the synthesis of elastin and collagen types I, III.
Hydrolyzed sodium hyaluronate (18 mg / <50 kDa): enhancement of intercellular signaling, relief of inflammation.
Release form:
Box contents: 2 sterile syringes with a volume of 3 ml each.
Active ingredient concentration: 90 mg of HA in one syringe (30 mg/ml).